Thank you for visiting our website
Dualsystems Biotech AG is a biotech company and we are specialise in providing services to elucidate protein-protein interaction.
You will find here some more information about our new product LRC – Ligand receptor capture.
TriCEPS-based ligand-receptor capture is a novel technology. LRC-TriCEPS enables the unbiased identification of cell surface receptors and off-targets on the living cells without genetic manipulation. Ligand-receptor capture technology can be used for many types of orphan ligands, such as peptides, proteins, antibodies, engineered affinity binders but also for viruses.
Now available: The next generation of LCR-TriCEPS
Video – how the LRC-TriCEPS technology works
Orphan ligands:
- Extracellular proteins
- Peptide ligands
- Antibodies
- Engineered affinity binders
- Viruses
Testimonials:
- BioMed
- Follicum
- Igenica Biotherapeutics
- QIMR Berghofer
- University of Miami
- Münster University Hospital
- University of Manitoba
- The Rockefeller University
- Medizinische Hochschule Hannover
- Igenica Biotherapeutics (USA)
- University of California San Francisco (UCSF)
- CEDOC – Centro de Estudos de Doenças Crónicas
- Washington University School of Medicine
For more information visit the LRC-TriCEPS Service page
